Dec 19 (Reuters) - Pyxis Oncology Inc Pyxs.o:

Breakings · Dec 20 05:35

Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on Its Lead Clinical Program, Pyx-201
Pyxis Oncology Inc - - Company
Pyxis Oncology Inc - Current Cash Runway Expected to Fund Development Into 2H 2026
Pyxis Oncology Inc - Will Focus Resources on Advancing Its Lead Asset, Pyx-201
Pyxis Oncology Inc - Second Clinical Program, Pyx-106 Is Being Deprioritized

Source Text: Id:Ngnx9Fjpzf

Further Company Coverage: Pyxs.o

((Reuters.briefs@Thomsonreuters.com;))

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

Risk Disclaimer